Ann Transplant Res | Volume 2, Issue 1 | Case Report | Open Access
Anantharaman R*, Arulkumar A, Madhusankar N, Kulasekaran M, Cherian S and Cherian KM
Department of Cardiology, Frontier Lifeline Hospital, India
*Correspondance to: Anantharaman R
Fulltext PDFCardiac Allograft Vasculopathy (CAV) is the 'Achilles heel' of long term outcome following heart transplant. Even though the overall outcomes for heart transplant has improved over the last 4 decades, with survival after heart transplant reported 90%, 80% and 60% at 1, 3 and 10 years respectively, the long term survival is determined mainly by presence or absence of CAV. In this report we discuss the first case of re-do heart transplant done in India for CAV, 8 years following the initial transplant done in 2009 and we discuss the underlying pathology, treatment options and possible preventions of CAV in the current era.
Heart transplantation; Cardiac allograft vasculopathy
Anantharaman R, Arulkumar A, Madhusankar N, Kulasekaran M, Cherian S, Cherian KM. India's 1st Case of Re-Do Heart Transplantation for Cardiac Allograft Vasculopathy: A Case Report and Review of Literature. Ann Transplant Res. 2018;1(3):1011.